Let's see if this one will also be deleted by the SA junta:
I love Seeking Alpha for providing quality stock analysts a professional platform to publish quality research. I, myself, am by no means in a league where I could research and put together an analyst report as thorough as this one. Respect !
As a disclaimer, I am long CTIX and up until now I have been very impressed with the science behind their various compounds. Most notably, I have been under the impression that the cancer compund, Kevetrin, and the antibiotic, Brilacidin, both show strong evidence of efficacy and that they are safe. I have been impressed with management's ability to drive the company forward without very much dilution.
Today, I realize that this was all smoke and mirrors and that I have been wrong.
I especially like the part where the office furniture is put under scrutiny. That was an eye opener for me. Never would I have gotten the ida of researching such a vital and important part of the business. I now fear that the latest surge in share price was not due to the FDA granting Brilacidin QIDP designation but merely a matter of speculation based on an unrealistic valuation of the 25 hight adjustable desks and the almost new canteen vending machine.
Market Data 
Markets 
AI
